Evidence map›Paper›PMID 36810121›Full record

ArticleWorld journal of surgical oncology2023

Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy.

Gizem Oner, Semen Önder, Hüseyin Karatay, Naziye Ak, Mustafa Tükenmez, Mahmut Müslümanoğlu, Abdullah İğci, Ahmet Dincçağ, Vahit Özmen, Adnan Aydiner and 2 more

Abstract readPublished Erratum
In one paragraph

Article in World journal of surgical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Gizem OnerDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Semen ÖnderDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Hüseyin KaratayDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Naziye AkDepartment of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey.
Mustafa TükenmezDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Mahmut MüslümanoğluDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Abdullah İğciDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Ahmet DincçağDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Vahit ÖzmenDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Adnan AydinerDepartment of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey.
Ekrem YavuzDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Neslihan CabioğluDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. neslicab@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36810121
PMCPMC9942286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.